PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 117 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2016. The put-call ratio across all filers is 5.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $704,000 | -47.9% | 267,000 | -29.7% | 0.04% | -54.2% |
| Q2 2017 | $1,352,000 | +298.8% | 379,800 | +325.3% | 0.08% | +196.4% |
| Q4 2016 | $339,000 | -1.2% | 89,300 | -5.2% | 0.03% | -37.8% |
| Q3 2015 | $343,000 | -62.6% | 94,200 | -40.9% | 0.04% | -64.8% |
| Q2 2015 | $916,000 | -33.6% | 159,400 | -32.7% | 0.13% | -33.7% |
| Q1 2015 | $1,379,000 | -34.8% | 236,700 | -12.3% | 0.19% | -45.8% |
| Q4 2014 | $2,116,000 | +46.5% | 269,900 | -8.4% | 0.36% | +64.1% |
| Q3 2014 | $1,444,000 | -37.8% | 294,700 | -22.0% | 0.22% | -37.1% |
| Q2 2014 | $2,322,000 | -18.1% | 377,600 | -28.6% | 0.34% | -21.8% |
| Q1 2014 | $2,835,000 | +246.6% | 529,100 | +238.1% | 0.44% | +210.6% |
| Q4 2013 | $818,000 | -14.9% | 156,500 | -10.3% | 0.14% | -35.5% |
| Q3 2013 | $961,000 | +284.4% | 174,500 | +75.7% | 0.22% | +228.4% |
| Q2 2013 | $250,000 | – | 99,300 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrone Advisors, LLC | 16,415,933 | $137,073,041 | 29.47% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,638,395 | $13,680,598 | 4.20% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $12,223,331 | 4.08% |
| VK Services, LLC | 2,632,784 | $21,983,746 | 2.93% |
| Iron Triangle Partners LP | 1,800,000 | $15,030,000 | 2.20% |
| BOURNE LENT ASSET MANAGEMENT INC | 574,350 | $4,795,822 | 2.11% |
| Deep Track Capital, LP | 6,000,000 | $50,100,000 | 1.93% |
| Jackson Square Partners, LLC | 6,933,865 | $57,897,773 | 1.93% |
| ARK Investment Management | 29,822,440 | $249,017,370 | 1.90% |
| Nikko Asset Management Americas, Inc. | 13,447,666 | $112,153,534 | 1.34% |